Opportunity Information: Apply for RFI 674 23 LIMPOPO
The "Limpopo Province Orphans and Vulnerable Children (OVC) Activity" opportunity (Funding Opportunity Number: RFI 674 23 LIMPOPO) is a Request for Information (RFI) issued by USAID South Africa (USAID-Pretoria) focused on gathering input rather than immediately awarding funding. The core purpose is to invite stakeholders and interested organizations to share information, ideas, and practical suggestions that can shape future OVC programming in Limpopo Province. In plain terms, USAID is doing market research to better understand what organizations are currently operating in the province, what services they deliver, what expertise they have, and how strong their capacity is to contribute to HIV epidemic control through OVC-focused interventions.
Because it is categorized as an "Other" opportunity using an "Other" funding instrument type, and because the listed award ceiling is 0 with no expected awards indicated, this notice should be read as a planning and intelligence-gathering step rather than a competitive grant solicitation. RFIs are commonly used to inform the design of a later funding opportunity, such as a cooperative agreement, contract, or grant. Submissions typically help the agency refine program scope, confirm what is feasible on the ground, identify service gaps, and understand which implementation approaches have the best chance of success in the local context.
The programmatic focus is on orphans and vulnerable children in Limpopo in a way that supports HIV epidemic control. While the notice text is brief, OVC programming in HIV contexts generally includes prevention and protection services for children and adolescents affected by HIV, support for caregivers and households, linkage to HIV testing and treatment services where appropriate, psychosocial support, school retention and educational support, violence prevention and response, and coordination with health and social service systems. By asking for "information and suggestions," USAID is signaling that it wants implementers to weigh in on what strategies work in Limpopo, what barriers exist (for example, geography, transport, stigma, documentation issues, school attendance challenges, or gaps in social welfare access), and what partnerships or referral networks are already functioning.
Eligibility is broad and is framed around "others," with explicit openness to multiple organization types and geographies. The notice references potential respondents including local entities, international organizations, and regional organizations, as well as various organization categories such as commercial entities, public sector bodies, educational institutions, and nonprofits. The RFI also provides a specific definition of a "local entity" tailored to South/Southern Africa. Under that definition, a local entity must be legally organized under the laws of South/Southern Africa, have its principal place of business or operations in South/Southern Africa, be majority owned by citizens or lawful permanent residents of South/Southern Africa, and be managed by a governing body where the majority are citizens or lawful permanent residents of South/Southern Africa. This definition matters because USAID often uses RFIs to assess not only technical experience but also the depth of local leadership and local operational presence, which can influence how a future solicitation is structured and what set-asides or preferences might be considered.
Administratively, the opportunity is tied to CFDA number 98.001 and sits in the health activity category. The original closing date listed is 2022-12-06, and the creation date is 2022-11-15. That timing suggests it was a time-bound request for inputs during program planning. Even though it is not an award announcement, responding to this kind of RFI can be strategically important for organizations that want to influence program design or position themselves for a later procurement or assistance competition. Typical useful RFI responses in this space would highlight organizational capacity in Limpopo, evidence of performance delivering OVC or HIV-related services, staffing and local footprint, relationships with clinics, schools, and social development structures, data and monitoring capabilities, safeguarding and child protection systems, and practical recommendations on how USAID can structure an activity to strengthen outcomes for vulnerable children and families while contributing to broader HIV epidemic control goals.Apply for RFI 674 23 LIMPOPO
- The South Africa USAID-Pretoria in the health sector is offering a public funding opportunity titled "Limpopo Province Orphans and Vulnerable Children Activity" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 98.001.
- This funding opportunity was created on 2022-11-15.
- Applicants must submit their applications by 2022-12-06. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: F23AS00100 Refuges Enhancement/Infrastructure
Previous opportunity: The State Component of the National Cooperative Geologic Mapping Program
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFI 674 23 LIMPOPO
Applicants also applied for:
Applicants who have applied for this opportunity (RFI 674 23 LIMPOPO) also looked into and applied for these:
| Funding Opportunity |
|---|
| Free State Province Orphans and Vulnerable Children Activity Apply for RFI 674 23 FREESTATE Funding Number: RFI 674 23 FREESTATE Agency: South Africa USAID-Pretoria Category: Health Funding Amount: Case Dependent |
| North West Province Orphans and Vulnerable Children Activity Apply for RFI 674 23 NORTHWEST Funding Number: RFI 674 23 NORTHWEST Agency: South Africa USAID-Pretoria Category: Health Funding Amount: Case Dependent |
| Cooperative Centers on Human Immunology (U19 Clinical Trial Optional) Apply for RFA AI 22 069 Funding Number: RFA AI 22 069 Agency: National Institutes of Health Category: Health Funding Amount: $2,500,000 |
| Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional) Apply for PAR 24 022 Funding Number: PAR 24 022 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed) Apply for PAR 23 025 Funding Number: PAR 23 025 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed) Apply for PAR 23 026 Funding Number: PAR 23 026 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Leading Equity and Diversity in the Medical Scientist Training Program (LEAD MSTP)(T32) Apply for PAR 23 030 Funding Number: PAR 23 030 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| International Centers of Excellence for Malaria Research (U19 Clinical Trial Not Allowed) Apply for RFA AI 22 067 Funding Number: RFA AI 22 067 Agency: National Institutes of Health Category: Health Funding Amount: $800,000 |
| Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 Clinical Trial Optional) Apply for PAR 23 054 Funding Number: PAR 23 054 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Research Infrastructure Development for Interdisciplinary Aging Studies (R61/R33 - Clinical Trial Optional) Apply for PAR 23 053 Funding Number: PAR 23 053 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Mozambique Local Tuberculosis Response II Apply for 72065623 RFI TBCONTROL Funding Number: 72065623 RFI TBCONTROL Agency: Mozambique USAID-Maputo Category: Health Funding Amount: Case Dependent |
| Social Drivers of Mental Illnesses in Low- and Middle-Income Countries: Mechanisms and Pathways of Interventions for Youth (R01 Clinical Trial Optional) Apply for RFA MH 23 310 Funding Number: RFA MH 23 310 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Mozambique Local Tuberculosis Response II Apply for 720656 RFI TBCONTROL Funding Number: 720656 RFI TBCONTROL Agency: Mozambique USAID-Maputo Category: Health Funding Amount: Case Dependent |
| Pragmatic Trials across the Cancer Control Continuum (UG3/UH3 Clinical Trial Required) Apply for PAR 22 256 Funding Number: PAR 22 256 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed) Apply for PAR 23 065 Funding Number: PAR 23 065 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Pilot Projects Enhancing Utility and Usage of Common Fund Data Sets (R03 Clinical Trial Not Allowed) Apply for RFA RM 23 003 Funding Number: RFA RM 23 003 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIH Research Evaluation and Commercialization Hubs (REACH) Awards (U01 Clinical Trial Optional) Apply for RFA OD 23 002 Funding Number: RFA OD 23 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Secondary Analysis of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21 Clinical Trial Not Allowed) Apply for PAR 23 036 Funding Number: PAR 23 036 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required) Apply for PAR 23 057 Funding Number: PAR 23 057 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIH Research Evaluation and Commercialization Hubs (REACH) Awards (U01 Clinical Trial Optional) Apply for RFA OD 23 005 Funding Number: RFA OD 23 005 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFI 674 23 LIMPOPO", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
